This inventor holds 1 USPTO granted patent. Top assignee: The University of Manchester. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Andrew Michael Brass - Innovator in Selective Glucocorticoid Receptor Agonists
Introduction
Andrew Michael Brass is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective glucocorticoid receptor agonists. His work focuses on innovative methods for treating various inflammatory conditions and malignancies.
Latest Patents
Andrew Michael Brass holds a patent for a method that addresses inflammatory conditions, haematological malignancies, immunosuppression, and transplant rejection. This invention involves administering a compound with specific structural formulas, which can be a pharmaceutically acceptable derivative or pro-drug. The patent outlines various compounds and their applications in medical treatments.
Career Highlights
Brass is affiliated with The University of Manchester, where he continues to advance research in his field. His work has garnered attention for its potential impact on therapeutic strategies for complex health issues.
Collaborations
He has collaborated with esteemed colleagues, including Stephen Alexander Barr and Michael A McKervey, contributing to a rich environment of innovation and research.
Conclusion
Andrew Michael Brass exemplifies the spirit of innovation in the pharmaceutical industry, with his work paving the way for new treatment methodologies. His contributions are vital in addressing significant health challenges through targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile